UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
NIBEC wins patent for peptide-based inducible pluripotent stem cell in US
by Lee Han-soo
2018-07-04 13:30
Biopharma stocks listed in H1 perform poorer than non-pharma peers
by Nam Doo-hyun
2018-07-03 15:08
Beijing Northland to go ahead with P3 clinical trials for VM202 in China
by Lee Han-soo
2018-06-29 15:44
Biogen purchases Samsung Bioepis’ share
by Lee Han-soo
2018-06-29 14:23
LG Chem launches Enbrel biosimilar in Korea
by Lee Han-soo
2018-06-28 12:23
라인
Prognostic marker for childhood obesity complications wins patent
by Nam Doo-hyun
2018-06-27 12:19
Antarctic sea microorganisms; a solution to blood shortage?
by Nam Doo-hyun
2018-06-26 14:44
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
by Nam Doo-hyun
2018-06-19 11:43
Celltrion completes FDA resubmission for Trastuzumab biosimilar
by Lee Han-soo
2018-06-18 17:43
Oral care probiotics research on rise
by Marian Chu
2018-06-18 15:20
라인
SCM, Toolgen to develop new stem cell treatment
by Lee Han-soo
2018-06-15 15:21
NIBEC wins to stem cell regeneration patent
by Lee Han-soo
2018-06-15 14:43
Nature Cell suspected of manipulating stock prices
by Lee Han-soo
2018-06-12 17:54
Celltrion launches new business platform
by Lee Han-soo
2018-06-05 17:49
Bio group takes part in US investment conference
by Lee Han-soo
2018-06-04 16:14
라인
Nature Cell applies for P3 clinical trials
by Lee Han-soo
2018-06-01 15:43
Biosimilars quickly catch up with originals in Korea
by So Jae-hyeon
2018-06-01 15:37
Korean biosimilar makers tap into Japan
by So Jae-hyeon
2018-05-30 15:41
LG Chem launches Enbrel biosimilar in Japan
by Lee Han-soo
2018-05-30 14:31
Will biotech stocks rebound on listings in H2?
by So Jae-hyeon
2018-05-30 11:33
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top